These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8314363)
1. Population pharmacokinetic analysis of new aminoglycosides, astromicin and isepamicin, and evaluation of Bayesian prediction method for approximation of individual clearance of drug. Uematsu T Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):606-10. PubMed ID: 8314363 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of gentamicin in horses. Martín-Jiménez T; Papich MG; Riviere JE Am J Vet Res; 1998 Dec; 59(12):1589-98. PubMed ID: 9858412 [TBL] [Abstract][Full Text] [Related]
4. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis. Zhou H; Mayer PR; Wajdula J; Fatenejad S J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641 [TBL] [Abstract][Full Text] [Related]
5. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A. Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146 [TBL] [Abstract][Full Text] [Related]
6. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. Matthews I; Kirkpatrick C; Holford N Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987 [TBL] [Abstract][Full Text] [Related]
7. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients. Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis. Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing. Xuan D; Nicolau DP; Nightingale CH Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy. Faltaos DW; Hulot JS; Urien S; Morel V; Kaloshi G; Fernandez C; Xuan kH; Leblond V; Lechat P Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of gentamicin in premature newborns. García B; Barcia E; Pérez F; Molina IT J Antimicrob Chemother; 2006 Aug; 58(2):372-9. PubMed ID: 16782742 [TBL] [Abstract][Full Text] [Related]
13. Comparison of two methods to obtain a desired first isepamicin peak in intensive care patients. Fauvelle F; Coulaud JM; Lecointre K; Tardy D; Poussel JF; Trape G Fundam Clin Pharmacol; 2001 Apr; 15(2):151-6. PubMed ID: 11468025 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma. Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371 [TBL] [Abstract][Full Text] [Related]
15. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus. Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418 [TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients. Latz JE; Chaudhary A; Ghosh A; Johnson RD Cancer Chemother Pharmacol; 2006 Apr; 57(4):401-11. PubMed ID: 16322991 [TBL] [Abstract][Full Text] [Related]
17. Single and multiple dose pharmacokinetics of gentamicin administered intravenously and intramuscularly in adult conditioned thoroughbred mares. Swan GE; Guthrie AJ; Mülders MS; Killeen VM; Nurton JP; Short CR; van den Berg JS J S Afr Vet Assoc; 1995 Sep; 66(3):151-6. PubMed ID: 8596186 [TBL] [Abstract][Full Text] [Related]
18. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation. Garrelts JC Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474 [TBL] [Abstract][Full Text] [Related]
19. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration. Burkhardt O; Kumar V; Katterwe D; Majcher-Peszynska J; Drewelow B; Derendorf H; Welte T J Antimicrob Chemother; 2007 Feb; 59(2):277-84. PubMed ID: 17185298 [TBL] [Abstract][Full Text] [Related]
20. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin. Hermida J; Tutor JC Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]